Vimarsana
Biggest News Aggregation in the World

Global Response Aid News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Global Response Aid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Global Response Aid Today - Breaking & Trending Today

Aditxt Signs Asset Purchase Agreement to Acquire Fifty Percent Ownership of Global Response Aid – with Rights to Manufacture and Market Broad-Spectrum Antiviral Drug Avigan - Vimarsana News

Aditxt Signs Asset Purchase Agreement to Acquire Fifty Percent Ownership of Global Response Aid – with Rights to Manufacture and Market Broad-Spectrum Antiviral Drug Avigan

This agreement is a significant step for Aditxt as it expands its portfolio to include innovative therapies for infectious diseases; Aditxt will partner with global logistics leader Agility to... | April 20, 2023

Crude Oil Down 2%; AT&T Shares Plunge After Q1 Results - Vimarsana News

Crude Oil Down 2%; AT&T Shares Plunge After Q1 Results

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 50 points on Thursday. The Dow traded down 0.26% to 33...

Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Vimarsana News

Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers Aditxt, Inc. (NASDAQ:ADTX) shares gained 68.6% to $1.45. Aditxt signed asset purchase agreement to acquire 50% ownership of Global Respo...

Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir - Vimarsana News

Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir

/PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and...

Cellvera Receives $20M Purchase Order for COVID-19 Oral Antiviral Avigan® - Vimarsana News

Cellvera Receives $20M Purchase Order for COVID-19 Oral Antiviral Avigan®

DUBAI, Arab Emirates - January 24, 2022 - (Newswire.com) Cellvera, a global biopharmaceutical company developing and commercializing innovative antiviral therapies, and the Global Response Aid today announced a supply of millions of its COVID-19 oral antiviral Avigan® to Malaysia in...